Today on Pharmaceutical Processing
Kodak stock down 30% after pharma deal put on hold
Trump signs executive order to help reshore pharmaceutical manufacturing
Regulatory See More >
U.S. to spend $1B for doses of J&J’s COVID-19 vaccine candidate
The U.S. Dept. of Health and Human Services and Defense Dept. agreed to a $1 billion deal for a vaccine candidate from Johnson & Johnson (NYSE:JNJ). HHS and DoD announced the agreement with Janssen Pharmaceutical, as the J&J subsidiary is set to offer large-scale manufacturing and the delivery of its COVID-19 vaccine candidate, with the federal…
Facility See More >
Hologic spending more than $50M to expand COVID-19 test production
Hologic (NSDQ:HOLX) is spending $50 million — including $14 million during its most recent quarter — to boost its production of COVID-19 tests. The U.S. government is providing $7.6 million to support the effort. Hologic’s business partner Stratec is also doubling the production of the Panther instruments that run Hologic assays. Get the full story on our sister site…
Moderna, Catalent partner on COVID-19 vaccine candidate manufacturing
Legacy Pharmaceutical Packaging buys facility to expand third-party logistics
Real estate firms tout former Bristol-Myers Squibb facility as an ‘innovation campus’
The Rapid Rise of Modular Construction—Are Standardized Facilities Next?
Supply Chain See More >
Could Honeywell’s glass bottles alternative help COVID-19 vaccine distribution?
Even as a host of companies rush to create COVID-19 vaccines, there’s another looming challenge: how to safely and quickly distribute them. Officials at Honeywell (NYSE:HON) think they have one potential solution with their Aclar Edge bottles and vials, touted as a safer alternative to glass packaging for pharmaceutical products. Kori Anderson, Honeywell’s healthcare packaging GM,…
Recalls See More >
Torrent Pharmaceuticals Issues Voluntary Nationwide Recall of Losartan Potassium Tablets
Torrent Pharmaceuticals Limited is voluntarily recalling two lots of Losartan potassium tablets, USP to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. The impurity detected in the API is N-nitrosodiethylamine (NDEA), which is a substance that occurs…
